|
Oct 14
|
Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?
|
|
Oct 14
|
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
|
|
Oct 14
|
Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade
|
|
Oct 14
|
FDA approves Pfizer’s HYMPAVZI to treat haemophilia
|
|
Oct 12
|
The past three years for Pfizer (NYSE:PFE) investors has not been profitable
|
|
Oct 12
|
2 Unstoppable Growth Stocks to Buy Right Now for Less than $200
|
|
Oct 12
|
2 Incredibly Cheap Big Pharma Stocks to Buy Now
|
|
Oct 12
|
3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With Less Than $100 Right Now
|
|
Oct 11
|
Pfizer’s Hympavzi Approved for Treatment of Certain Types of Hemophilia
|
|
Oct 11
|
Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
|
|
Oct 11
|
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors
|
|
Oct 11
|
Activist investor Starboard cries foul play in exec U-turn at Pfizer
|
|
Oct 11
|
An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock
|
|
Oct 11
|
Pfizer reports positive data from prostate cancer combination therapy trial
|
|
Oct 11
|
FDA clears Roche breast cancer drug; Turnstone lays off 60% of staff
|
|
Oct 10
|
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
|
|
Oct 10
|
Why Pfizer Stock Tumbled by Nearly 3% on Thursday
|
|
Oct 10
|
Pfizer: Starboard Value pushes for investigation of board
|
|
Oct 10
|
Pfizer Investor Starboard Seeks Probe as 2 Former Executives Pull Out of Potential Activist Campaign
|
|
Jul 29
|
Pfizer Stock Is on a Hot Streak. Earnings Could Determine Its Next Move.
|